On the public citation graph

Medication -Induced Rhabdomyolysis: A Disproportionality Analysis of the FAERS Data

0 signed · 39 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/mus.25972openalex-extracted
Levetiracetam‐induced rhabdomyolysis: Analysis of reports from the Food and Drug Administration's Adverse Event Reporting System database
inferredcites →https://doi.org/10.1002/pds.1001openalex-extracted
The reporting odds ratio and its advantages over the proportional reporting ratio
inferredcites →https://doi.org/10.1002/pds.677openalex-extracted
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
inferredcites →https://doi.org/10.1007/s002280050466openalex-extracted
A Bayesian neural network method for adverse drug reaction signal generation
inferredcites →https://doi.org/10.1007/s11096-022-01472-xopenalex-extracted
Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system
inferredcites →https://doi.org/10.1007/s11845-019-01968-yopenalex-extracted
Spectrum of rhabdomyolysis in an acute hospital
inferredcites →https://doi.org/10.1007/s40211-020-00377-3openalex-extracted
Paliperidonpalmitat-induzierte Rhabdomyolyse
inferredcites →https://doi.org/10.1016/j.amjcard.2021.11.026openalex-extracted
Potential Safety Signals for Rhabdomyolysis Associated With High-Potency Statin Use With or Without Sacubitril/Valsartan
inferredcites →https://doi.org/10.1016/j.ecl.2022.01.004openalex-extracted
Safety of Statins and Nonstatins for Treatment of Dyslipidemia
inferredcites →https://doi.org/10.1016/j.jad.2023.11.025openalex-extracted
Safety assessment of Brexpiprazole: Real-world adverse event analysis from the FAERS database
inferredcites →https://doi.org/10.1016/j.medcle.2021.09.010openalex-extracted
Rhabdomyolysis: A syndrome to be considered
inferredcites →https://doi.org/10.1016/j.seizure.2023.07.003openalex-extracted
Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system
inferredcites →https://doi.org/10.1016/j.seizure.2024.03.009openalex-extracted
Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database
inferredcites →https://doi.org/10.1038/clpt.2011.295openalex-extracted
A Screening Study of Drug–Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel
inferredcites →https://doi.org/10.1038/s41598-023-39482-yopenalex-extracted
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database
inferredcites →https://doi.org/10.1056/nejmra0801327openalex-extracted
Rhabdomyolysis and Acute Kidney Injury
inferredcites →https://doi.org/10.1080/00031305.1999.10474456openalex-extracted
Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System
inferredcites →https://doi.org/10.1080/01926230590908213openalex-extracted
Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity
inferredcites →https://doi.org/10.1097/jes.0b013e31826c169eopenalex-extracted
Effect of Statins on Skeletal Muscle
inferredcites →https://doi.org/10.1111/bcp.15655openalex-extracted
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta‐analysis of randomized controlled trials
inferredcites →https://doi.org/10.1111/bcp.15684openalex-extracted
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?
inferredcites →https://doi.org/10.1111/bcp.15711openalex-extracted
Concomitant use of statins and sodium‐glucose co‐transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis
inferredcites →https://doi.org/10.1111/jgh.16411openalex-extracted
A pharmacovigilance study of association between proton‐pump inhibitors and rhabdomyolysis event based on FAERS database
inferredcites →https://doi.org/10.1136/ejhpharm-2022-003533openalex-extracted
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine
inferredcites →https://doi.org/10.1177/1060028018783519openalex-extracted
Rhabdomyolysis With Abiraterone Exposure: A Brief Review of the Food and Drug Administration Adverse Event Reporting System (FAERS)
inferredcites →https://doi.org/10.1177/10600280221148031openalex-extracted
Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)
inferredcites →https://doi.org/10.1177/10600280231156270openalex-extracted
Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases
inferredcites →https://doi.org/10.1177/20420986231154075openalex-extracted
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database
inferredcites →https://doi.org/10.1186/s13613-020-0645-1openalex-extracted
Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients
inferredcites →https://doi.org/10.1242/jeb.041178openalex-extracted
Unmasking the Janus face of myoglobin in health and disease
inferredcites →https://doi.org/10.2147/imcrj.s34919openalex-extracted
Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone
inferredcites →https://doi.org/10.2169/internalmedicine.8168-21openalex-extracted
Rhabdomyolysis Caused by Gefitinib Overdose
inferredcites →https://doi.org/10.2174/1574886318666230227143627openalex-extracted
Statin Associated Muscular Adverse Effects
inferredcites →https://doi.org/10.3389/fphar.2022.1039867openalex-extracted
Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
inferredcites →https://doi.org/10.3389/fphar.2023.1197470openalex-extracted
Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study
inferredcites →https://doi.org/10.3389/fphar.2024.1278442openalex-extracted
A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam
inferredcites →https://doi.org/10.3389/fphar.2024.1338902openalex-extracted
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database
inferredcites →https://doi.org/10.3390/jcm12103548openalex-extracted
Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System
inferredcites →https://doi.org/10.34172/aim.2023.08openalex-extracted
Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.